Description

Terlipressin Diacetate is a synthetic vasopressin analog peptide, chemically known as N-[N-(N-glycylglycyl)glycyl]-8-L-lysinevasopressin. It is a prodrug of lysine-vasopressin, which acts as a selective vasopressin V1 receptor agonist. Terlipressin Diacetate is utilized in laboratory research to study vasoconstriction, blood pressure regulation, and related physiological processes. It is manufactured under GMP standards, ensuring high purity and consistency. For laboratory research use only.

Product Specifications

Mechanism of Action & Research Applications

Terlipressin Diacetate is a synthetic vasopressin analog that, upon enzymatic cleavage, releases lysine-vasopressin, a potent vasoconstrictor. It selectively binds to vasopressin V1 receptors, leading to vasoconstriction and increased mean arterial pressure. This mechanism is particularly useful in studying conditions like hepatorenal syndrome and septic shock in laboratory settings. For laboratory research use only.

Side Effects (For Reference Only in Models)

In laboratory models, Terlipressin Diacetate may induce vasoconstriction, leading to increased blood pressure. Potential side effects include ischemia in peripheral tissues, electrolyte imbalances, and alterations in renal function. These effects are context-dependent and should be considered when designing experiments. For laboratory research use only.

Disclaimer

This product is intended strictly for laboratory research use only. It is not approved for human or veterinary use. Handling should follow institutional safety protocols.